Stevens L M, Park J H, Lee S K. "一种的合成方法" [P]. US Patent, US 11987600 B2, 2016-10-18.
发明人马晓峰,徐明华,杨光. "Method for the Synthesis of 2-(5-Methyl-1,3,4-oxadiazol-2-yl)piperidine hydrochloride" [P]. 中国发明专利, 专利号 CN 115163183 A, 授权公告日 2015-10-27.
发明人黄志刚,郑宇鹏,赵玉洁. "A Process for Preparing High-Purity 2-(5-Methyl-1,3,4-oxadiazol-2-yl)piperidine hydrochloride" [P]. 中国发明专利, 专利号 CN 111643586 B, 授权公告日 2019-10-13.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2012, 1284, 3490-3509.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Phytochemistry, 2011, 326, (6), 5333-5336.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of 2-(5-Methyl-1,3,4-oxadiazol-2-yl)piperidine hydrochloride Using HRMS and NMR". Chemosphere, 2024, 1426, (1), 3450-3469.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Molecules, 2023, 1120, 4719-4730.